Evidence map›Paper›PMID 27867382›Full record

ArticleFrontiers in immunology2016

IL-1β, But Not Programed Death-1 and Programed Death Ligand Pathway, Is Critical for the Human Th17 Response to

Emmanuel Stephen-Victor, Varun Kumar Sharma, Mrinmoy Das, Anupama Karnam, Chaitrali Saha, Maxime Lecerf, Caroline Galeotti, Srinivas V Kaveri, Jagadeesh Bayry

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. P2X7 Receptor Expression and Signaling on Dendritic Cells and CD4Frontiers in cell and developmental biology · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Emmanuel Stephen-VictorInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, France; UMR S 1138, Sorbonne Universités, UPMC Univ Paris, Paris, France; Centre de Recherche des Cordeliers, Equipe - Immunopathology and Therapeutic Immunointervention, Paris, France.
Varun Kumar SharmaInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, France; Centre de Recherche des Cordeliers, Equipe - Immunopathology and Therapeutic Immunointervention, Paris, France.
Mrinmoy DasInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, France; UMR S 1138, Sorbonne Universités, UPMC Univ Paris, Paris, France; Centre de Recherche des Cordeliers, Equipe - Immunopathology and Therapeutic Immunointervention, Paris, France.
Anupama KarnamInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, France; UMR S 1138, Sorbonne Universités, UPMC Univ Paris, Paris, France; Centre de Recherche des Cordeliers, Equipe - Immunopathology and Therapeutic Immunointervention, Paris, France.
Chaitrali SahaInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, France; Centre de Recherche des Cordeliers, Equipe - Immunopathology and Therapeutic Immunointervention, Paris, France.
Maxime LecerfInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, France; UMR S 1138, Sorbonne Universités, UPMC Univ Paris, Paris, France; Centre de Recherche des Cordeliers, Equipe - Immunopathology and Therapeutic Immunointervention, Paris, France; UMR S 1138, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Caroline GaleottiInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, France; UMR S 1138, Sorbonne Universités, UPMC Univ Paris, Paris, France; Centre de Recherche des Cordeliers, Equipe - Immunopathology and Therapeutic Immunointervention, Paris, France.
Srinivas V KaveriInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, France; UMR S 1138, Sorbonne Universités, UPMC Univ Paris, Paris, France; Centre de Recherche des Cordeliers, Equipe - Immunopathology and Therapeutic Immunointervention, Paris, France; UMR S 1138, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Jagadeesh BayryInstitut National de la Santé et de la Recherche Médicale Unité 1138, Paris, France; UMR S 1138, Sorbonne Universités, UPMC Univ Paris, Paris, France; Centre de Recherche des Cordeliers, Equipe - Immunopathology and Therapeutic Immunointervention, Paris, France; UMR S 1138, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Inserm · FRDélégation Paris 5 · FRSorbonne Paris Cité · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The programed death-1 (PD-1)-programed death ligand-1 (PD-L1) and PD-L2 co-inhibitory pathway has been implicated in the evasion strategies of

Indexed as

dendritic cellsIL-1βIL-23monocytesMycobacterium tuberculosisPD-1PD-L1Th17

Identifiers

PMID27867382
PMCPMC5095489
OpenAlexW2547161002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.